Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
Deutsche Medizinische Wochenschrift (1946)|May 11, 1984
[Naftidrofuryl in arterial occlusive disease. Controlled multicenter double-blind study with oral administration]U Maass, H G Amberger, H Böhme, et al.
Deutsche Medizinische Wochenschrift (1946)|October 30, 2008
[Comparison of two coronary risk equivalents: diabetes mellitus and peripheral arterial disease]H Darius, H J Trampisch, D Pittrow, et al.
Deutsche Medizinische Wochenschrift (1946)|May 19, 1989
[Iloprost, a stable prostacyclin derivative, in stage 4 arterial occlusive disease. A placebo-controlled multicenter study]C Diehm, O Abri, G Baitsch, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|December 4, 2004
High prevalence of peripheral arterial disease and low treatment rates in elderly primary care patients with diabetesS Lange, C Diehm, H Darius, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|May 1, 1997
Improvement in the quality of life after i.v. PGE1 therapy for intermittent claudicationA Creutzig, M Bullinger, M Cachovan, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|August 1, 1993
Treatment of patients with peripheral arterial occlusive disease Fontaine stage IV with intravenous iloprost and PGE1: a randomized open controlled studyH O Altstaedt, B Berzewski, H K Breddin, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|December 26, 2003
[DRG-based cost analysis of inpatient conservative treatment of stage III/IV peripheral arterial occlusive disease]H Heidrich, W Rogatti, E Altmann, et al.
Journal of Internal Medicine|December 24, 2010
Asymmetric dimethylarginine as an independent risk marker for mortality in ambulatory patients with peripheral arterial diseaseR H Böger, H G Endres, E Schwedhelm, et al.
Pageof 10